Comparing two drugs for heavy menstrual bleeding
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study compares two medications, calcium dobesilate and tranexamic acid, to see which works better for reducing heavy menstrual bleeding. If you have heavy periods and are otherwise healthy, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 39 years old.
- You have heavy menstrual bleeding (menorrhagia).
- You do not have certain pelvic conditions like fibroids, adenomyosis, or cancers of the reproductive organs.
- You do not have serious medical problems like liver disease, heart disease, migraines, kidney disease, thyroid issues, or bleeding disorders.
- You are not pregnant, breastfeeding, using an IUD or birth control pills, and have not had a blood clot before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medication called BT-114143 for people with heavy menstrual bleeding (abnormal uterine bleeding). The goal is to see if it is safe and effective in reducing blood loss during periods.
This study tests if a medicine called tranexamic acid can safely reduce heavy bleeding during periods for people who are taking blood thinners for a recent blood clot. It is a pilot study to see if a larger trial is possible.
This early-stage study tests medicines that may help control heavy uterine bleeding by changing how blood clots work in the uterus. If you have regular periods and meet the setup rules, you may be asked to provide menstrual tracking and undergo an endometrial (uterine lining) biopsy.
This trial tests if relugolix can reduce heavy menstrual bleeding caused by uterine fibroids. It may be an option for women who want to avoid surgery.
This study compares two medications (tranexamic acid and oxytocin) given directly into the uterus during a planned cesarean section to see which works better at reducing blood loss. It is for women with a single, full-term pregnancy and no major health complications.
This trial tests a capsule called CMS-D002 for heavy periods caused by uterine fibroids. It might help reduce your bleeding if you have fibroids at least 2 cm in size, regular cycles, and are between 18 and 50.
Hear when a new Menorrhagia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.